Xuqi Sun

438 total citations
27 papers, 282 citations indexed

About

Xuqi Sun is a scholar working on Hepatology, Oncology and Surgery. According to data from OpenAlex, Xuqi Sun has authored 27 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 13 papers in Oncology and 11 papers in Surgery. Recurrent topics in Xuqi Sun's work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Cancer, Lipids, and Metabolism (6 papers). Xuqi Sun is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Cancer, Lipids, and Metabolism (6 papers). Xuqi Sun collaborates with scholars based in China, Sweden and United States. Xuqi Sun's co-authors include Minshan Chen, Jie Mei, Wen‐Ping Lin, Yaojun Zhang, Jinbin Chen, Lianghe Lu, Shaohua Li, Rong Guo, Li Xu and Wei Peng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Science and European Journal of Cancer.

In The Last Decade

Xuqi Sun

25 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuqi Sun China 8 192 115 76 72 71 27 282
Songqiang Zhou China 9 178 0.9× 107 0.9× 69 0.9× 82 1.1× 49 0.7× 15 294
Michinori Hamaoka Japan 10 190 1.0× 136 1.2× 76 1.0× 55 0.8× 68 1.0× 38 283
Youen Lin China 4 193 1.0× 87 0.8× 51 0.7× 60 0.8× 29 0.4× 6 284
Zili Hu China 12 135 0.7× 103 0.9× 69 0.9× 68 0.9× 74 1.0× 35 316
Satheesh Chiradoni Thungappa India 4 201 1.0× 174 1.5× 67 0.9× 71 1.0× 32 0.5× 13 305
Fei Cao China 10 232 1.2× 64 0.6× 72 0.9× 82 1.1× 42 0.6× 32 293
Alexander Vasilyev Russia 2 196 1.0× 158 1.4× 66 0.9× 74 1.0× 32 0.5× 3 284
Yu-Jie Xu China 6 246 1.3× 82 0.7× 64 0.8× 75 1.0× 37 0.5× 10 307
Maria Aurelia Barbera Italy 9 104 0.5× 134 1.2× 60 0.8× 70 1.0× 53 0.7× 19 284

Countries citing papers authored by Xuqi Sun

Since Specialization
Citations

This map shows the geographic impact of Xuqi Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuqi Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuqi Sun more than expected).

Fields of papers citing papers by Xuqi Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuqi Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuqi Sun. The network helps show where Xuqi Sun may publish in the future.

Co-authorship network of co-authors of Xuqi Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Xuqi Sun. A scholar is included among the top collaborators of Xuqi Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuqi Sun. Xuqi Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qisha, Jingjing Wang, Yutong Yao, et al.. (2025). Intratumor Rhodococcus sp. B513 drives DEN-induced hepatocellular carcinoma progression by modulating gut microbiota and angiogenesis. Current Research in Microbial Sciences. 9. 100428–100428.
2.
Zhang, Jia, Chun-Yu Lai, Xuanwen Bao, et al.. (2025). Injectable celastrol-loading emulsion hydrogel for immunotherapy of low-immunogenic cancer. Journal of Nanobiotechnology. 23(1). 183–183. 4 indexed citations
3.
Zhang, Jia, Chun-Yu Lai, Bin Li, et al.. (2025). Injectable HMME‐Loading Emulsion Hydrogel for Ultrasound‐Triggered Release and Enhanced Sonodynamic Immunotherapy. Advanced Healthcare Materials. 15(1). e00410–e00410. 1 indexed citations
4.
Cheng, Xiaofei, Kai Han, Xuqi Sun, et al.. (2024). A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study. Cancer Letters. 585. 216663–216663. 5 indexed citations
5.
Gu, Chen, et al.. (2024). Impact of treatment interval between neoadjuvant immunochemotherapy and surgery in lung squamous cell carcinoma. BMC Cancer. 24(1). 585–585. 1 indexed citations
6.
Sun, Xuqi, et al.. (2024). Optimal therapeutic strategy for non-small cell lung cancer with thoracic extrathoracic metastasis: a study based on SEER database. Journal of Thoracic Disease. 16(2). 1021–1033. 1 indexed citations
8.
Wang, Yangyang, Wei Zhang, Jiangchao Wu, et al.. (2023). Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation. BMC Cancer. 23(1). 86–86. 1 indexed citations
9.
Sun, Xuqi, et al.. (2023). Pathological complete response to neoadjuvant alectinib in unresectable anaplastic lymphoma kinase positive non-small cell lung cancer: A case report. World Journal of Clinical Cases. 11(22). 5322–5328. 1 indexed citations
10.
Sun, Xuqi, Cao Chen, Ke Sun, et al.. (2023). Development and Validation of Novel Models Including Tumor Micronecrosis for Predicting the Postoperative Survival of Patients with Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 1181–1194. 1 indexed citations
11.
Hu, Zili, Yu Yuan, Qingbo Liu, et al.. (2022). Development and Validation of Prognostic Nomograms for Hepatocellular Carcinoma After Hepatectomy Based on Inflammatory Markers. Journal of Hepatocellular Carcinoma. Volume 9. 1403–1413. 2 indexed citations
14.
Pan, Yangxun, Xuqi Sun, Zili Hu, et al.. (2021). Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients. Journal of Hepatocellular Carcinoma. Volume 8. 657–670. 15 indexed citations
15.
Mei, Jie, Shaohua Li, QiJiong Li, et al.. (2021). Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 8. 167–176. 44 indexed citations
16.
Sun, Xuqi, Jie Mei, Wen‐Ping Lin, et al.. (2021). Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients. BMC Cancer. 21(1). 775–775. 55 indexed citations
17.
Wang, Juncheng, Jiancong Chen, Bing Yang, et al.. (2021). Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection. European Journal of Cancer. 155. 85–96. 20 indexed citations
18.
Sun, Xuqi, Dandan Hu, Zheng Liu, et al.. (2020). <p>Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy</p>. Journal of Hepatocellular Carcinoma. Volume 7. 337–345. 9 indexed citations
19.
Sun, Xuqi, et al.. (2020). Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification. Cancer Imaging. 20(1). 42–42. 5 indexed citations
20.
Sun, Xuqi, Dandan Hu, Yaojun Zhang, et al.. (2020). <p>Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?</p>. SHILAP Revista de lepidopterología. Volume 7. 377–384. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026